Senomyx, Inc. ended the 1st quarter of 2012 with $8.2 million in revenue and $51.3 million in cash and highly liquid investments. Its forecast for 2012 includes a $7–10 million net loss, and diluted shares loss of $0.18–$0.25 per share.
Firmenich's announcement last month that it would extend research and development funding for Senomyx's Sweet Taste program through July 2013. Sucrose enhancer S6973 and sucralose enhancer S2383 are two products of the program. Both have GRAS status and are expected to be more widely marketed this year. The company is anticipating GRAS status for sucrose enhancer S9632 in 2012.
In the 1st quarter, Firmenich (a partner in the company's Cooling Taste program) selected a new cooling agent, S5031, for development, so another project of Senomyx's for 2012 will be getting regulatory support for that.